There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks
Learn more about Ipamorelin Peptide Therapy CJC-1295 may be discussed during provider-guided peptide consultations for patients interested in growth hormone pathway support, recovery, body composition, wellness optimization, and healthy aging goals
Entendemos que iniciar un programa de prdida de peso puede resultar abrumador, pero no tiene por qu hacerlo solo
Evidence boundary No published human randomized trial has evaluated long-term injectable GHK-Cu for skin, hair, or wound endpoints